| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/RCCM.2104003 |
| P698 | PubMed publication ID | 12070057 |
| P2093 | author name string | Maureen D Mayes | |
| Judith Abrams | |||
| Reda E Girgis | |||
| Manish K Gugnani | |||
| P2860 | cites work | The L-arginine-nitric oxide pathway | Q24304874 |
| Airway nitric oxide diffusion in asthma: Role in pulmonary function and bronchial responsiveness | Q28376746 | ||
| Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules | Q33610044 | ||
| Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension | Q34294101 | ||
| Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension | Q35563263 | ||
| High resolution computed tomography as a predictor of lung histology in systemic sclerosis | Q36564691 | ||
| Interactions of oxidant stress and vascular reactivity | Q37697954 | ||
| The pulmonary pathologic manifestations of the CREST syndrome | Q37922592 | ||
| Role of nitric oxide in autoimmunity | Q40402341 | ||
| High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial | Q41671784 | ||
| Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection | Q45763818 | ||
| Single-exhalation profiles of NO and CO2 in humans: effect of dynamically changing flow rate | Q46082857 | ||
| A two-compartment model of pulmonary nitric oxide exchange dynamics | Q46127369 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1587-1591 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Partitioning of alveolar and conducting airway nitric oxide in scleroderma lung disease. | |
| P478 | volume | 165 |
| Q46395932 | A new and more accurate technique to characterize airway nitric oxide using different breath-hold times |
| Q45994046 | A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. |
| Q34409752 | ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. |
| Q46949329 | Abnormal exhaled ethane concentrations in scleroderma |
| Q43498450 | Airway diffusing capacity of nitric oxide and steroid therapy in asthma |
| Q38670757 | Application of nitric oxide measurements in clinical conditions beyond asthma |
| Q37808134 | Biomarkers of Scleroderma Lung Disease: Recent Progress |
| Q60912200 | Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review |
| Q46127878 | Characterizing airway and alveolar nitric oxide exchange during tidal breathing using a three-compartment model |
| Q46232814 | Examining axial diffusion of nitric oxide in the lungs using heliox and breath hold |
| Q58702183 | Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension |
| Q37672615 | Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease |
| Q33568617 | Exhaled nitric oxide in diagnosis and management of respiratory diseases |
| Q37555421 | Exhaled nitric oxide in pulmonary arterial hypertension associated with systemic sclerosis |
| Q99634847 | Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review |
| Q41984856 | Increased alveolar nitric oxide concentration and high levels of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis |
| Q28391347 | Levels of Exhaled Breath Condensate pH and Fractional Exhaled Nitric Oxide in Retired Coal Miners |
| Q35651184 | Modeling pulmonary nitric oxide exchange |
| Q33930836 | Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: a pilot feasibility study. |
| Q37321403 | Non-invasive measurement of the haemodynamic effects of inhaled salbutamol, intravenous L-arginine and sublingual nitroglycerin |
| Q37097729 | Partitioned exhaled nitric oxide to non-invasively assess asthma |
| Q39401141 | Plasma Vascular Endothelial Growth Factor Concentration and Alveolar Nitric Oxide as Potential Predictors of Disease Progression and Mortality in Idiopathic Pulmonary Fibrosis |
| Q47967050 | Pulmonary function, diffusing capacity, and inflammation in healthy and asthmatic subjects exposed to ultrafine particles |
| Q35055456 | Tuberculosis, lung infections, interstitial lung disease, and journalology in AJRCCM 2002. |
Search more.